{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:56:49Z","timestamp":1793642209722,"version":"4.5.1"},"reference-count":37,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,8,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cytokine storm syndromes (CSS) are severe hyperinflammatory conditions characterized by excessive immune system activation leading to organ damage and death. Hemophagocytic lymphohistiocytosis (HLH), a disease often associated with inherited defects in cell-mediated cytotoxicity, serves as a prototypical CSS for which the 5-year survival is only 60%. Frontline therapy for HLH consists of the glucocorticoid dexamethasone (DEX) and the chemotherapeutic agent etoposide. Many patients, however, are refractory to this treatment or relapse after an initial response. Notably, many cytokines that are elevated in HLH activate the JAK\/STAT pathway, and the JAK1\/2 inhibitor ruxolitinib (RUX) has shown efficacy in murine HLH models and humans with refractory disease. We recently reported that cytokine-induced JAK\/STAT signaling mediates DEX resistance in T cell acute lymphoblastic leukemia (T-ALL) cells, and that this could be effectively reversed by RUX. On the basis of these findings, we hypothesized that cytokine-mediated JAK\/STAT signaling might similarly contribute to DEX resistance in HLH, and that RUX treatment would overcome this phenomenon. Using ex vivo assays, a murine model of HLH, and primary patient samples, we demonstrate that the hypercytokinemia of HLH reduces the apoptotic potential of CD8 T cells leading to relative DEX resistance. Upon exposure to RUX, this apoptotic potential is restored, thereby sensitizing CD8 T cells to DEX-induced apoptosis in vitro and significantly reducing tissue immunopathology and HLH disease manifestations in vivo. Our findings provide rationale for combining DEX and RUX to enhance the lymphotoxic effects of DEX and thus improve the outcomes for patients with HLH and related CSS.<\/jats:p>","DOI":"10.1182\/blood.2020006075","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T10:28:10Z","timestamp":1591957690000},"page":"657-668","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":96,"title":["JAK\/STAT pathway inhibition sensitizes CD8 T cells to dexamethasone-induced apoptosis in hyperinflammation"],"prefix":"10.1182","volume":"136","author":[{"given":"Lauren K.","family":"Meyer","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of California, San Francisco, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine C.","family":"Verbist","sequence":"additional","affiliation":[{"name":"Department of Oncology, St. Jude Children\u2019s Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrin","family":"Albeituni","sequence":"additional","affiliation":[{"name":"Department of Oncology, St. Jude Children\u2019s Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooks P.","family":"Scull","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, TX; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel C.","family":"Bassett","sequence":"additional","affiliation":[{"name":"Department of Oncology, St. Jude Children\u2019s Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa N.","family":"Stroh","sequence":"additional","affiliation":[{"name":"Department of Oncology, St. Jude Children\u2019s Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9623-2812","authenticated-orcid":false,"given":"Heather","family":"Tillman","sequence":"additional","affiliation":[{"name":"Department of Pathology, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl E.","family":"Allen","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, TX; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1790-2679","authenticated-orcid":false,"given":"Michelle L.","family":"Hermiston","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of California, San Francisco, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5581-6555","authenticated-orcid":false,"given":"Kim E.","family":"Nichols","sequence":"additional","affiliation":[{"name":"Department of Oncology, St. Jude Children\u2019s Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2","key":"2020080611245108000_B1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.pcl.2012.03.002","article-title":"Making sense of the cytokine storm: a conceptual framework for understanding, diagnosing, and treating hemophagocytic syndromes","volume":"59","author":"Canna","year":"2012","journal-title":"Pediatr Clin North Am"},{"issue":"6","key":"2020080611245108000_B2","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/art.40071","article-title":"Review: cytokine storm syndrome: looking toward the precision medicine era","volume":"69","author":"Behrens","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"2020080611245108000_B3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.coi.2007.04.007","article-title":"Apoptosis induced by the lymphocyte effector molecule perforin","volume":"19","author":"Bolitho","year":"2007","journal-title":"Curr Opin Immunol"},{"issue":"3","key":"2020080611245108000_B4","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-10-3413","article-title":"An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder","volume":"104","author":"Jordan","year":"2004","journal-title":"Blood"},{"issue":"4","key":"2020080611245108000_B5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nri.2017.1","article-title":"Immune regulation by glucocorticoids","volume":"17","author":"Cain","year":"2017","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2020080611245108000_B6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1146\/annurev.ge.19.120185.001233","article-title":"Steroid receptor regulated transcription of specific genes and gene networks","volume":"19","author":"Yamamoto","year":"1985","journal-title":"Annu Rev Genet"},{"issue":"23","key":"2020080611245108000_B7","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1182\/blood.2018894618","article-title":"Recommendations for the management of hemophagocytic lymphohistiocytosis in adults","volume":"133","author":"La Ros\u00e9e","year":"2019","journal-title":"Blood"},{"issue":"25","key":"2020080611245108000_B8","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1182\/blood-2017-06-788349","article-title":"Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study","volume":"130","author":"Bergsten","year":"2017","journal-title":"Blood"},{"issue":"1","key":"2020080611245108000_B9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.cdd.4400969","article-title":"Recent insights into the mechanism of glucocorticosteroid-induced apoptosis","volume":"9","author":"Distelhorst","year":"2002","journal-title":"Cell Death Differ"},{"issue":"1","key":"2020080611245108000_B10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4049\/jimmunol.149.1.107","article-title":"IL-4 and IL-2 selectively rescue Th cell subsets from glucocorticoid-induced apoptosis","volume":"149","author":"Zubiaga","year":"1992","journal-title":"J. Immunol"},{"issue":"45","key":"2020080611245108000_B11","doi-asserted-by":"crossref","first-page":"72608","DOI":"10.18632\/oncotarget.11618","article-title":"Janus and PI3-kinases mediate glucocorticoid resistance in activated chronic leukemia cells","volume":"7","author":"Oppermann","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"2020080611245108000_B12","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1038\/leu.2017.136","article-title":"JAK\/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias","volume":"31","author":"Delgado-Martin","year":"2017","journal-title":"Leukemia"},{"issue":"7","key":"2020080611245108000_B13","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.4049\/jimmunol.151.7.3460","article-title":"Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids","volume":"151","author":"Kam","year":"1993","journal-title":"J. Immunol"},{"issue":"2","key":"2020080611245108000_B14","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1172\/JCI130189","article-title":"Glucocorticoids paradoxically facilitate steroid resistance in T cell acute lymphoblastic leukemias and thymocytes","volume":"130","author":"Meyer","year":"2020","journal-title":"J Clin Invest"},{"issue":"13","key":"2020080611245108000_B15","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1182\/blood-2015-12-684399","article-title":"Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis","volume":"127","author":"Das","year":"2016","journal-title":"Blood"},{"issue":"7","key":"2020080611245108000_B16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1515\/hsz-2016-0107","article-title":"iBH3: simple, fixable BH3 profiling to determine apoptotic priming in primary tissue by flow cytometry","volume":"397","author":"Ryan","year":"2016","journal-title":"Biol Chem"},{"issue":"5","key":"2020080611245108000_B17","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1177\/1087057114521867","article-title":"A new bliss independence model to analyze drug combination data","volume":"19","author":"Zhao","year":"2014","journal-title":"J Biomol Screen"},{"issue":"11","key":"2020080611245108000_B18","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1182\/blood.V89.11.4100","article-title":"Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis","volume":"89","author":"Osugi","year":"1997","journal-title":"Blood"},{"issue":"6","key":"2020080611245108000_B19","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jpeds.2011.11.046","article-title":"Diagnostic accuracy of a specific cytokine pattern in hemophagocytic lymphohistiocytosis in children","volume":"160","author":"Xu","year":"2012","journal-title":"J Pediatr"},{"issue":"3","key":"2020080611245108000_B20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nri3156","article-title":"The role of interleukin-2 during homeostasis and activation of the immune system","volume":"12","author":"Boyman","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2020080611245108000_B21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/1074-7613(95)90141-8","article-title":"The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15","volume":"2","author":"Lin","year":"1995","journal-title":"Immunity"},{"issue":"suppl 1","key":"2020080611245108000_B22","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/sj.cdd.4401456","article-title":"Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance","volume":"11","author":"Schmidt","year":"2004","journal-title":"Cell Death Differ"},{"issue":"2","key":"2020080611245108000_B23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1182\/blood-2014-05-576470","article-title":"Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cells","volume":"125","author":"Jing","year":"2015","journal-title":"Blood"},{"issue":"1","key":"2020080611245108000_B24","doi-asserted-by":"crossref","first-page":"e86790","DOI":"10.1371\/journal.pone.0086790","article-title":"Identification of STAT5A and STAT5B target genes in human T cells","volume":"9","author":"Kanai","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"2020080611245108000_B25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1182\/blood.2019000761","article-title":"Mechanisms of action of ruxolitinib in murine models of hemophagocytic lymphohistiocytosis","volume":"134","author":"Albeituni","year":"2019","journal-title":"Blood"},{"issue":"5441","key":"2020080611245108000_B26","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1126\/science.286.5441.952","article-title":"TCR-mediated internalization of peptide-MHC complexes acquired by T cells","volume":"286","author":"Huang","year":"1999","journal-title":"Science"},{"issue":"1","key":"2020080611245108000_B27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1182\/blood-2011-06-363994","article-title":"Critical role for perforin and Fas-dependent killing of dendritic cells in the control of inflammation","volume":"119","author":"Chen","year":"2012","journal-title":"Blood"},{"issue":"4","key":"2020080611245108000_B28","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.immuni.2019.03.028","article-title":"The \u03b3c family of cytokines: basic biology to therapeutic ramifications","volume":"50","author":"Leonard","year":"2019","journal-title":"Immunity"},{"issue":"6","key":"2020080611245108000_B29","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.jaci.2018.10.068","article-title":"IFN-\u03b3 and CD25 drive distinct pathologic features during hemophagocytic lymphohistiocytosis","volume":"143","author":"Humblet-Baron","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"2020080611245108000_B30","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/eji.1830260204","article-title":"Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression","volume":"26","author":"Akbar","year":"1996","journal-title":"Eur J Immunol"},{"key":"2020080611245108000_B31","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.3389\/fimmu.2017.01809","article-title":"Life and death of activated T cells: how are they different from na\u00efve T cells?","volume":"8","author":"Zhan","year":"2017","journal-title":"Front Immunol"},{"issue":"2","key":"2020080611245108000_B32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00018-015-2062-4","article-title":"The common \u03b3-chain cytokine receptor: tricks-and-treats for T cells","volume":"73","author":"Waickman","year":"2016","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"2020080611245108000_B33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/MMBR.05015-11","article-title":"Into the eye of the cytokine storm","volume":"76","author":"Tisoncik","year":"2012","journal-title":"Microbiol Mol Biol Rev"},{"issue":"3","key":"2020080611245108000_B34","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/bjh.16174","article-title":"A journey through infectious risk associated with ruxolitinib","volume":"187","author":"Sant\u2019Antonio","year":"2019","journal-title":"Br J Haematol"},{"issue":"3","key":"2020080611245108000_B35","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ajh.24976","article-title":"Ruxolitinib-associated infections: A systematic review and meta-analysis","volume":"93","author":"Lussana","year":"2018","journal-title":"Am J Hematol"},{"issue":"7","key":"2020080611245108000_B36","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.bbmt.2017.03.029","article-title":"Ruxolitinib as salvage therapy in steroid-refractory acute graft-versus-host disease in pediatric hematopoietic stem cell transplant patients","volume":"23","author":"Khandelwal","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"2020080611245108000_B37","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/pbc.25575","article-title":"A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: a Children\u2019s Oncology Group phase 1 consortium study (ADVL1011)","volume":"62","author":"Loh","year":"2015","journal-title":"Pediatr Blood Cancer"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/136\/6\/657\/1750748\/bloodbld2020006075.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/136\/6\/657\/1750748\/bloodbld2020006075.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T04:50:39Z","timestamp":1696222239000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/136\/6\/657\/460898\/JAKSTAT-pathway-inhibition-sensitizes-CD8-T-cells"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,8,6]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2020006075","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.738133842.793575697","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,6]]}}}